HeartWorks and Mayo Clinic launch a clinical trial that involves surgically injecting lab-grown cardiac tissue—sourced from the patients’ skin cells—in people with congenital heart disease.
Your experiences, your questions, and your voice help shape what comes next at HeartWorks.
Learn what induced pluripotent stem cells (iPSCs) are, how scientists create them, and why they are important for regenerative medicine and heart disease research.
What if patients helped shape the future of medical research?
Through The Co-op @ HeartWorks, the congenital heart disease community is helping researchers learn from real experiences – turning stories into data that may help advance care and clinical trials.
Learn more about how patient-powered research works.
